Research Archive — Page 16 of 131
-
March 5, 2025
Team finds a better way to identify newborns at risk for opioid withdrawal
By 2017, on the back of the opioid crisis, the rate of neonatal opioid withdrawal syndrome in the U.S. was estimated to have reached 7.3 per 1000 deliveries. Meanwhile, many newborns exposed to opioids in utero never develop the syndrome and must undergo needless monitoring in the hospital after birth. -
March 4, 2025
Skin tone may affect accuracy of blood oxygen measurement in children: study
One of two commonly used oximetry devices failed to detect low oxygen levels in 7% of patients with the darkest skin tone. -
March 3, 2025
Jeffrey Rathmell named to leadership role in cancer research at the University of Chicago
Rathmell has been named chair of the Ben May Department for Cancer Research and director of the Ludwig Center at the University of Chicago, effective July 1. -
February 27, 2025
VUMC part of new study validating curative therapy for sickle cell disease
Of 38 adults with severe SCD who participated in the study, more than 97% no longer required immunosuppressive therapy one year after the transplant. -
February 26, 2025
Vanderbilt University School of Medicine fifth in the nation in NIH research funding
The NIH is the world’s largest public funder of biomedical research. VUSM, which received $586 million in direct and indirect NIH grant support in FY24, has been among the top 10 recipients of NIH funding among U.S. medical schools for nine of the past 15 years. -
February 24, 2025
Bottling a mouse ‘superpower’ may heal lungs damaged by premature birth: study
Watch the video to hear Jennifer Sucre, MD, talk about how this study upends what people are taught about how the lung develops. Using a four-dimensional microscopy technique, researchers at Vanderbilt have created 3D video images of mouse lung tissue grown in the laboratory. -
February 21, 2025
Study shows end-of-life cancer care lacking for Medicare patients
The study involved patients of diverse ethnic backgrounds age 66 or older who died from breast, prostate, pancreatic or lung cancers.